Skip to main content

acetylcysteine (Aceteff®)

 

Status: Medicine does not meet criteria for AWMSG assessment

Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.

Medicine details

Medicine name acetylcysteine (Aceteff®)
Formulation 600 mg effervescent tablet
Reference number 3429
Indication

Adjunctive mucolytic therapy for respiratory tract disorders associated with excessive, viscous mucous secretions in adults and adolescents 14 years of age and over

Company Dunelm Pharmaceuticals Ltd
BNF chapter Respiratory system
Submission type N/A
Status Medicine does not meet criteria for AWMSG assessment
Date of issue 16/06/2017
Follow AWTTC: